Evonile Pharma Limited

In plain words

Price: 34.6% below its 52-week high of ₹2,588.8.

Delivery: 42.3% of traded shares were kept for delivery over the last 10 sessions, against 46.1% over the last 60.

A description of the data, not a recommendation.

17/100 · Weak over the last ~60 sessions, data 2026-10-30

• Delivery vs usual 10/30: Delivery 36.3% over the last 20 sessions vs 21.7% in the 40 before (1.67x); shares delivered per day 0.59x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
• Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
• Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
• Mutual fund holding 2/15: 1 scheme hold it, about ₹2 cr in all (as of 2026-09-30). Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
• Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
• Promoter pledges 5/5: No promoter pledge filings in 90 days.

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.